USD10
LXEO Shares
About Lexeo TherapeuticsLexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

USD10
LXEO Shares
About Lexeo TherapeuticsLexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Stats

TRADING WINDOW

Closed

OPENS AT

Not enough data

MARKET CAP

$368.27M

OPEN PRICE

$4.47

LOW (1Y)

$3.60

HIGH (1Y)

$10.99

LOW (24H)

$4.47

HIGH (24H)

$4.75

VOLUME (24H)

$730.14K

6.42%

Price history

Time
Price
Change
Today
$4.47
4.92%
1 Day
$4.54
3.42%
1 Week
$4.79
2.09%
1 Month
$5.16
9.02%
1 Year
$3.96
18.43%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.